Literature DB >> 31320191

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2019 Report: Future Challenges.

José Luis López-Campos1, Juan José Soler-Cataluña2, Marc Miravitlles3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31320191     DOI： 10.1016/j.arbres.2019.06.001

Source DB:  PubMed          Journal:  Arch Bronconeumol (Engl Ed)        ISSN： 0300-2896            Impact factor:   4.872


× No keyword cloud information.
  31 in total

1.  COPD Patients Have a Restricted Breathing Pattern That Persists with Increased Metabolic Demands.

Authors:  Jennifer M Yentes; Farahnaz Fallahtafti; William Denton; Stephen I Rennard
Journal:  COPD       Date:  2020-04-17       Impact factor: 2.409

2.  An in silico and in vitro integrated analysis method to reveal the curative mechanisms and pharmacodynamic substances of Bufei granule on chronic obstructive pulmonary disease.

Authors:  Yuan-Yuan Ma; Rong Li; Zhi-Xian Shang; Wei Liu; Xin-Yi Jiao; Liu-Yi Liang; Rui Liu; Zheng Li
Journal:  Mol Divers       Date:  2022-03-09       Impact factor: 2.943

3.  Correlation Analysis of Early Renal Injury in Elderly Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Authors:  Dong Zhang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-09-06

4.  Use of capnography for prediction of obstruction severity in non-intubated COPD and asthma patients.

Authors:  Barak Pertzov; Michal Ronen; Dror Rosengarten; Dorit Shitenberg; Moshe Heching; Yael Shostak; Mordechai R Kramer
Journal:  Respir Res       Date:  2021-05-21

5.  Atrial fibrillation in Mexican population: Differences in presentation, comorbidities and risk factors between men and women

Authors:  Humberto Rodríguez-Reyes; César I Laguna-Muñoz; Carlos F Gallegos-de Luna; Manuel O de-Los-Ríos-Ibarra; José L Salas-Pacheco; José L Leyva-Pons; Luz M Muñoz-Gutiérrez; Arturo Vargas-Hernandez; Karla M Rodríguez-Muñoz; Jaime Barragán-Luna; Marco A Alcocer-Gamba; Jorge Cortez-Lawrenz; Julio Farjat-Ruiz
Journal:  Arch Cardiol Mex       Date:  2022-07-01

6.  Factors associated with coronary heart disease in COPD patients and controls.

Authors:  Christina D Svendsen; Karel K J Kuiper; Kristoffer Ostridge; Terje H Larsen; Rune Nielsen; Vidar Hodneland; Eli Nordeide; Per S Bakke; Tomas M Eagan
Journal:  PLoS One       Date:  2022-04-27       Impact factor: 3.752

7.  Effect of PIFR-based optimised inhalation therapy in patients recovering from acute exacerbation of chronic obstructive pulmonary disease: protocol of a prospective, multicentre, superiority, randomised controlled trial.

Authors:  Jianlan Hua; Wei Zhang; Hui-Fang Cao; Chun-Ling Du; Jia-Yun Ma; Yi-Hui Zuo; Jing Zhang
Journal:  BMJ Open       Date:  2020-05-07       Impact factor: 2.692

8.  Patients' self-reported receipt of brief smoking cessation interventions based on a decision support tool embedded in the healthcare information system of a large general hospital in China.

Authors:  Shuilian Chu; Lirong Liang; Hang Jing; Di Zhang; Zhaohui Tong
Journal:  Tob Induc Dis       Date:  2019-10-18       Impact factor: 2.600

Review 9.  Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials.

Authors:  Hong Chen; Jian Sun; Qiang Huang; Yongqi Liu; Mengxin Yuan; Chunlan Ma; Hao Yan
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

10.  Effects of a comprehensive, inpatient pulmonary rehabilitation programme in a cachectic patient with very severe COPD and chronic respiratory failure.

Authors:  Frits M E Franssen; Lowie E G W Vanfleteren; Daisy J A Janssen; Emiel F M Wouters; Martijn A Spruit
Journal:  Breathe (Sheff)       Date:  2019-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.